Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
IImmuno-Biological Laboratories Co.,Ltd. logo
4570TSE Growth

Immuno-Biological Laboratories Co.,Ltd.

免疫生物研究所 Yahoo Finance

Recent & upcoming events

Aug 7
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 24
Shareholder meeting 22:00
Shareholders' meeting
Venue: ビエント高崎 602号室 群馬県高崎市問屋町2-7 Details
Add to Google Calendar
May 13
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Oct 30
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
2027
Jan 29
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Apr 23
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Jul 16
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥1.00B YoY +3.7%
Operating income ¥281M margin 28.0%
Net income ¥329M YoY +32.1%
EPS ¥35 YoY +32.1%
P/E —
ROE 19.6% Equity ratio 86% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥1.09B +8.2%
Operating income ¥322M +14.5%
Net income ¥347M +5.5%
EPS ¥37 +5.5%

Quarterly fundamentals

Income & cash flow
Quarter FY22 Q4FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1
Revenue ¥262M¥240M¥177M¥188M¥183M¥268M
Operating income ¥73M¥39M¥577,000¥14M¥-4M¥94M
Net income ¥60M¥-213M¥11M¥16M¥-6M¥166M
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

国内機関 3.8%個人 15.8%未開示 77.3%202120222023202420252026
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

清藤　勉 12.1%清藤　勉楽天証券株式会社共有口 2.7%楽天証券株式会社共有口株式会社トランスジェニックグループ 1.7%株式会社トランスジェニックグループ中沢　祥子 1.1%中沢　祥子株式会社東和銀行 1.1%株式会社東和銀行土井　勝之 1%土井　勝之林　剛徳 0.9%林　剛徳林　ラヒム 0.8%林　ラヒム野村證券株式会社 0.7%野村證券株式会社NOMURA INTERNATION 0.7%NOMURA INTERNATIONAL PLC A/C JAPAN FLOW（常任代理人野村證券株式会社）202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
清藤 勉 1,123,700 12.1% Yuho (EDINET)
楽天証券株式会社共有口 253,300 2.7% Yuho (EDINET)
株式会社トランスジェニックグループ 160,000 1.7% Yuho (EDINET)
中沢 祥子 101,600 1.1% Yuho (EDINET)
株式会社東和銀行 100,000 1.1% Yuho (EDINET)
土井 勝之 95,000 1.0% Yuho (EDINET)
林 剛徳 82,500 0.9% Yuho (EDINET)
林 ラヒム 70,000 0.8% Yuho (EDINET)
野村證券株式会社 63,100 0.7% Yuho (EDINET)
NOMURA INTERNATIONAL PLC A/C JAPAN FLOW 62,500 0.7% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

7/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 15.3%
✓ Positive operating cash flow ¥301M
✓ ROA improved YoY 13.5% → 15.3%
✗ Operating CF exceeds net income (accrual quality) OCF ¥301M / net income ¥329M
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 82.1% → 85.5%
✓ Current ratio improved 4.94× → 5.68×
✓ No dilution (shares outstanding did not increase) 9,314,590 → 9,314,590
✓ Gross margin improved 65.4% → 70.4%
✗ Asset turnover improved 0.53× → 0.47×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 85.5%
Current ratio 5.7×
Years of positive operating CF 5 of last 10 yrs
Payout ratio 18%
Latest fiscal year result Profit (net income ¥329M)

Performance history

Last 10 years
0億円3億円5億円8億円10億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 7.427.587.815.776.036.487.958.179.7010.0
Operating income -11.6-0.49-1.74-5.95-2.41-1.220.581.042.092.81
Ordinary income -11.7-0.49-1.56-6.79-3.11-2.43-1.501.252.103.01
Net income -20.9-0.53-1.67-6.68-3.19-2.59-2.901.872.493.29
Total assets 34.333.029.923.718.417.114.316.218.521.6
Equity 13.420.221.519.516.313.710.812.715.118.4

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥-288¥-7¥-20¥-76¥-34¥-28¥-31¥20¥27¥35
ROE ———————15.9%17.9%19.6%
Operating CF -0.560.74-2.44-6.09-1.94-0.930.261.341.833.01
Investing CF -4.58-0.06-5.930.11-0.17-1.560.30-0.24-0.54-1.16
Financing CF 21.5-1.38-1.260.81-2.161.440.010.01-0.32-0.27
FCF -5.140.68-8.37-5.98-2.11-2.490.561.091.301.85

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

High ROE ✓ 3-year revenue growth ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data